Global $94.6 Bn Contract Pharmaceutical Manufacturing Market, 2022

News provided by

Research and Markets

22 Sep, 2017, 12:15 GMT

DUBLIN, September 22, 2017 /PRNewswire/ --

The "Global Contract Pharmaceutical Manufacturing Market - By Dose Formulation Type, Region - Market Size, Demand Forecasts, Industry Trends and Updates(2016-2022)" report has been added to Research and Markets' offering.

Global Contract Pharmaceutical manufacturing market is estimated to reach $94.63 billion by 2022 from $65.55 billion in 2016, at a CAGR of 6.31% for the forecasted period. Solid dose formulation constituted 42% of the market in 2016.

Contract Pharmaceutical manufacturing is a process of outsourcing certain production activities to third party manufacturers. These manufacturers are given the chemical formulation by pharma companies. This type of contract manufacturing is witnessing a rising trend as more and more pharma companies are trying to focus more on R&D of drugs rather than getting involved in the production of drugs in order to gain competitive advantage in the business. This industry is classified into API manufacturing and Finished Dosage formulation(FDF) manufacturing. FDF formulation is further divided into solid dose formulation, liquid dose formulation and injectable dose formulation.

North America holds the major share in Global Contract Pharmaceutical manufacturing market. Asia-Pacific-especially India-is the fastest growing market. US, Canada, China, India, Japan and Australia are main countries operating in this industry.

Increasing consumption of medicines around the globe, aging population, increasing rate of approvals, adoption of novel manufacturing technologies, increasing demand for generic drugs, robust pipeline of drugs and increasing number of patent expires are some of the factors fuelling the growth of this industry.Availability of skilled workforce and lower labour cost are some of the factors propelling the rapid growth of Asia-Pacific market.Increasing complexity of clinical trials, lack of in-house laboratory capacity are some of the challenges in this industry.

Major companies operating in Contract Pharmaceutical manufacturing industry include HAUPT Pharma AG, Abbott Laboratories,Pfizer,Catalent Pharma Solutions, Althea Technologies and Nipro Corp.Several firms have acquired contract service providers to achieve vertical integration. Mergers and Acquisitions are also one of the key strategies being adopted by various companies.Pharma companies are also turning to contract packaging companies for novel packaging solutions. Also there is a transition from vertically integration to an ecosystem of interconnected suppliers by major players.

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Market Overview

  • Definition
  • Value Chain Analysis
  • Porter's 5 Forces
  • Regulations

4. Market Dynamics

  • Introduction
  • Drivers
  • Constraints
  • Opportunities

5. Global Contract Pharmaceutical Manufacturing market Segmentation, Forecasts and Trends - By Revenue

6. By Dose Formulation type

  • Solid Dose Formulation
  • Liquid Dose Formulation
  • Injectable Dose Formulation

7. By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Switzerland
  • Others
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Others
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Others
  • MEA
  • UAE
  • Saudi Arabia
  • South Africa
  • Others

8. Vendor Market Share Analysis

9. Company Profiles

  • Catalent Pharma Solutions
  • Lonza
  • Royal DSM
  • Patheon
  • Vetter Pharma
  • Patheon
  • Dr. Reddy's Laboratories
  • Euticals
  • Recipharm
  • Baxter BioPharma Solutions
  • Biomeva
  • Boehringer Ingelheim
  • Aenova
  • Jubilant
  • Zhejiang Hisun Pharmaceutical
  • Famar
  • Shandong Xinhua Pharmaceutical
  • Esteve Qumica
  • Evonik Degussa
  • Fareva
  • AbbVie Contract Manufacturing
  • Divis Laboratories
  • Aurobindo Pharma
  • Pfizer CentreSource
  • Nipro Corporation
  • Teva API
  • Daito Pharmaceutical
  • Others

10. Industry Structure

  • Industry M&As, Consolidations
  • Investment Opportunities

11. Global Pharmaceutical Contract Manufacturing market - Road Ahead

  • Tables
  • Disclaimer

For more information about this report visit https://www.researchandmarkets.com/research/m3ljmn/global_contract

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com